Immune cells could be doing much more than we think in protecting our eyes – Jefferson researchers uncover new details. 

New Research shows that women treated for melanoma have twice the mortality rate of men when given two immunotherapies at one time. 

In a first-ever study, a unique spiritual practice called orgasmic meditation, has been found to produce a distinctive pattern of brain function.

Learning how a flexible, inexpensive and non-invasive tool can be used to diagnose and stage common diseases from cancer to heart attack.

Examining addiction’s impact on family members and the importance of cultural humility.

Eight years after being named President of Thomas Jefferson University and CEO of Jefferson Health, Stephen K. Klasko, MD, MBA, will retire from his position, effective December 31, 2021.

Advocating for vulnerable populations to improve the care experience and health outcomes. 

CAR-T cells are less sensitive than other types of immunotherapy in detecting and killing melanoma cells, a finding that could help improve immunotherapy sensitivity. 

Plans national Consensus Conference on Research in Telehealth

Using sensory integration therapy tools can help patients and families live more successful and satisfying lives.